Streetbeat News

Earnings

NEO

NeoGenomics (NASDAQ:NEO) received mixed ratings from 4 analysts, with an average 12-month price target of $21.25, reflecting a 6.26% decline from the previous target. The company, specializing in cancer-focused genetic testing, shows a revenue growth of 17.99% but struggles with profitability, having a net margin of -12.19% and ROE of -1.95%. Despite these challenges, its debt-to-equity ratio of 0.64 indicates a sound financial structure.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 12:00 pm

CSGP

CoStar Group (NASDAQ:CSGP) received mixed analyst ratings over the last quarter, with a shift towards more bullish views in the last 30 days. The average 12-month price target for CSGP has risen to $93.4, up 8.19% from the previous $86.33. Analyst actions include adjustments to ratings and price targets by firms such as Needham, JMP Securities, Goldman Sachs, and BMO Capital. CoStar Group, a leader in commercial real estate data, has shown strong financial performance with significant revenue growth, high net margin, and excellent ROE and ROA, positioning it above industry averages.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 12:00 pm

GIL

Gildan Activewear projects its FY24 revenue growth to range from flat to a low-single digit increase. The company also forecasts its FY24 adjusted EPS to be between $2.92 and $3.07, compared to the $3 estimate.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:59 am

XPRO

Expro Gr Hldgs (NYSE:XPRO) reported Q4 adjusted EPS of $0.06, missing the $0.10 estimate, a 72.73% decrease from last year. Sales were $406.75M, beating the $382.91M estimate, up 15.89% from last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:59 am

GIL

Gildan Activewear (NYSE:GIL) reported Q4 adjusted EPS of $0.75, surpassing the $0.73 estimate, and sales of $783M, exceeding the $764.48M estimate. This represents a 15.38% increase in earnings and an 8.75% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:55 am

EXC

Exelon Corporation has announced its adjusted operating EPS guidance for 2024, projecting a range of $2.40 to $2.50. This forecast slightly exceeds the estimated average of $2.41.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:54 am

EXC

Exelon (NASDAQ:EXC) reported Q4 adjusted earnings of $0.60 per share, surpassing the $0.58 estimate, marking a 39.53% increase from last year. Sales reached $5.37B, beating the $4.17B estimate, a 15.02% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:53 am

NVDA

PANW

QQQ

SPY

Wall Street is focused on Nvidia's upcoming Q4 earnings amid a tech selloff and concerns over Federal Reserve's future interest rate decisions. Tuesday's market downturn was influenced by mixed retail earnings, Nvidia earnings anxiety, and a decline in the leading economic index. Futures and specific stocks like Palo Alto Networks showed premarket declines, while the market anticipates Fed minutes and speeches for interest rate clues. Notable companies are scheduled for earnings reports, affecting stock movements.

Portfolio Pulse from Shanthi Rexaline

February 21, 2024 | 11:51 am

DAN

Dana Incorporated (NYSE:DAN) announced its plan to sell its European hydraulics business to HPI Group, aiming to streamline its portfolio and focus on industrial system sales. The deal includes operations in Italy, France, and Germany, and is expected to close in the first half of 2024, pending regulatory approvals. This unit generated approximately $90 million in sales last year. Dana reported Q4 sales of $2.494 billion, missing expectations, and forecasts FY24 sales between $10.65 billion and $11.15 billion.

Portfolio Pulse from Nabaparna Bhattacharya

February 21, 2024 | 11:40 am

WWW

Wolverine World Wide provided its fiscal year 2024 revenue and adjusted EPS forecasts, which are both below analysts' estimates. The company expects FY24 revenue to be between $1.70 billion and $1.75 billion, compared to the estimated $1.95 billion. Additionally, Wolverine projects its FY24 adjusted EPS to range from $0.65 to $0.85, versus the $0.85 estimate.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 11:38 am